Skip to content

The impact of dexmedetomidine on postoperative delirium in OSA patients

The impact of dexmedetomidine on postoperative delirium in OSA patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108088
Enrollment
Unknown
Registered
2025-08-25
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age > 18 years old, regardless of gender; 2. complete informed consent; 3. the ability to understand and complete the research questionnaire; 4. no history of neurocognitive dysfunction; 5. scheduled non-cardiac elective surgery under general anesthesia; 6. ASA 1 ~ 3; 7. the surgery duration is 2 ~ 5 hours.

Exclusion criteria

Exclusion criteria: 1. Age < 18 years old; 2. Neurosurgery; 3. schizophrenia or active psychosis; 4. history of drug or alcohol dependence or abuse in the past three months; 5. dementia or obvious nervous system diseases (such as stroke, epilepsy, intracranial tumor, Parkinson's disease, etc.); 6. heart rate < 50 beats / min, sick sinus syndrome, severe heart block.

Design outcomes

Primary

MeasureTime frame
postoperative delirium;

Secondary

MeasureTime frame
Postoperative pain score;Length of hospital stay;Complications within 30 days after surgery;

Countries

China

Contacts

Public ContactYi Zou

Beijing Friendship Hospital, Capital Medical University

zouyi871123@126.com+86 10 6313 8780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 20, 2026